Hepatitis B virus DNA prediction rules for hepatitis B e antigen–negative chronic hepatitis B
Jordan J. Feld, Melissa Ayers, Dahlia El‐Ashry, Tony Mazzulli, Raymond Tellier, E. Jenny Heathcote – 25 July 2007 – After hepatitis B e antigen (HBeAg) seroconversion, hepatitis B may become inactive or progress to HBeAg‐negative hepatitis with persistent or intermittent alanine aminotransferase (ALT) elevation. The aim of this study was to prospectively identify factors predictive of the clinical course in HBeAg‐negative chronic hepatitis B (CHB). Patients were stratified by ALT and HBeAg status and followed every 3 months for up to 5 years.